Therefore, our studies suggest that a reduction in plasma AG:UAG, coupled with the inability of hippocampal cells to acylate UAG (via GOAT), leads to reduced GHS-R1a signaling in the GCL and cognitive deficits manifest in PDD. The gene discussed is MBOAT4; the disease is Cognitive impairment.